Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Precision Medicine
Pharma
McKesson acquires Maryland CRO for $2.25 billion
Healthcare conglomerate McKesson has dropped $2.25 billion for Precision Medicine Group's R&D and commercialization capabilities.
Donavyn Coffey
Aug 25, 2026 11:22am
Novartis charts next US investment with new radiopharma plant
Jan 9, 2026 10:30am
Roche touts Tecentriq biomarker win in bladder cancer
Aug 18, 2025 4:17pm
Blueprint exec spots key Ayvakit expansion, dealmaking plan
Aug 11, 2022 11:34am
Takeda beefs up digital content team, AI amid Exkivity launch
Apr 6, 2022 1:54pm
Oncologists impressed with Novartis prostate cancer radiotherapy
Feb 23, 2022 7:10am
